Abacus FCF Advisors LLC Purchases 64,742 Shares of Colgate-Palmolive (NYSE:CL)

Abacus FCF Advisors LLC increased its holdings in Colgate-Palmolive (NYSE:CL - Free Report) by 66.5% in the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 162,163 shares of the company's stock after buying an additional 64,742 shares during the period. Colgate-Palmolive comprises approximately 2.4% of Abacus FCF Advisors LLC's holdings, making the stock its 12th biggest position. Abacus FCF Advisors LLC's holdings in Colgate-Palmolive were worth $15,195,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Kohmann Bosshard Financial Services LLC bought a new stake in Colgate-Palmolive in the 4th quarter valued at about $26,000. Centricity Wealth Management LLC bought a new stake in shares of Colgate-Palmolive during the fourth quarter valued at approximately $27,000. Vermillion Wealth Management Inc. acquired a new position in shares of Colgate-Palmolive during the fourth quarter worth approximately $31,000. Union Bancaire Privee UBP SA bought a new position in Colgate-Palmolive in the 4th quarter worth approximately $32,000. Finally, Briaud Financial Planning Inc acquired a new stake in Colgate-Palmolive in the 4th quarter valued at approximately $32,000. Institutional investors and hedge funds own 80.41% of the company's stock.

Colgate-Palmolive Stock Up 0.1%

NYSE CL traded up $0.08 during trading on Wednesday, reaching $92.02. The company's stock had a trading volume of 5,353,809 shares, compared to its average volume of 4,740,439. The company has a current ratio of 0.92, a quick ratio of 0.58 and a debt-to-equity ratio of 13.40. The stock has a market capitalization of $74.57 billion, a PE ratio of 26.14, a PEG ratio of 4.20 and a beta of 0.38. Colgate-Palmolive has a 1-year low of $85.32 and a 1-year high of $109.30. The business has a 50-day moving average price of $91.63 and a 200-day moving average price of $91.13.

Colgate-Palmolive (NYSE:CL - Get Free Report) last issued its quarterly earnings data on Friday, April 25th. The company reported $0.91 earnings per share for the quarter, beating analysts' consensus estimates of $0.86 by $0.05. The business had revenue of $4.91 billion for the quarter, compared to the consensus estimate of $4.92 billion. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. The firm's revenue was down 3.0% compared to the same quarter last year. During the same period last year, the business earned $0.86 EPS. On average, research analysts forecast that Colgate-Palmolive will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive announced that its Board of Directors has authorized a share repurchase plan on Thursday, March 20th that authorizes the company to repurchase $5.00 billion in outstanding shares. This repurchase authorization authorizes the company to repurchase up to 6.8% of its stock through open market purchases. Stock repurchase plans are typically a sign that the company's board of directors believes its stock is undervalued.

Colgate-Palmolive Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, May 15th. Shareholders of record on Thursday, April 17th were given a $0.52 dividend. This is an increase from Colgate-Palmolive's previous quarterly dividend of $0.50. This represents a $2.08 annualized dividend and a yield of 2.26%. The ex-dividend date was Thursday, April 17th. Colgate-Palmolive's payout ratio is currently 58.76%.

Analysts Set New Price Targets

A number of brokerages have recently commented on CL. Wall Street Zen lowered Colgate-Palmolive from a "buy" rating to a "hold" rating in a report on Wednesday, May 7th. UBS Group raised their target price on shares of Colgate-Palmolive from $105.00 to $109.00 and gave the company a "buy" rating in a research note on Thursday, April 17th. Wells Fargo & Company upped their price target on shares of Colgate-Palmolive from $83.00 to $88.00 and gave the stock an "underweight" rating in a research note on Wednesday, April 2nd. Barclays decreased their price objective on shares of Colgate-Palmolive from $89.00 to $86.00 and set an "equal weight" rating for the company in a report on Friday, April 11th. Finally, Citigroup boosted their target price on Colgate-Palmolive from $103.00 to $108.00 and gave the stock a "buy" rating in a report on Monday, April 28th. One analyst has rated the stock with a sell rating, ten have given a hold rating and ten have issued a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of "Hold" and an average target price of $102.12.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.